Smith+Nephew Facing Questions About Knee Franchise Future

Smith+Nephew's logo

Smith+Nephew reported 2Q21 orthopedic revenue of USD $930.8 million, +55% vs. 2Q20. Compared to 2Q19, the company grew +2.6% for the quarter. Smith+Nephew remains on track to achieve its 2021 underlying growth guidance of 10% to 13% vs 2020.

While the company's hip franchise has gained some traction in recent quarters, its knee business is...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us